Baseline predictors of progression of Parkinson’s disease in a sample of Egyptian patients: clinical and biochemical

Author's Department

Institute of Global Health & Human Ecology

Find in your Library

https://ejnpn.springeropen.com/track/pdf/10.1186/s41983-022-00445-1

All Authors

Asmaa Helmy, Eman Hamid, Mohamed Salama, Ahmed Gaber, Mahmoud El-Belkimy, Ali Shalash

Document Type

Research Article

Publication Title

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Publication Date

Winter 1-15-2022

doi

https://doi.org/10.1186/s41983-022-00445-1

Abstract

Background: Clinical progression of Parkinson's disease (PD) is highly heterogeneous, and its predictors are generally lacking. Identifying predictors of early disease progression is important for patients' management and follow-up. The current study aims to identify clinical, neuroimaging and biochemical baseline predictors of motor progression in patients with PD. Forty-five PD patients were assessed at baseline, 6 months and 1 year using MDS-UPDRS total and subscores, Hoehn and Yahr (H&Y), Schwab and England (S&E), International Physical Activity Questionnaire (IPAQ). Baseline New Freezing of Gait Questionnaire (NFOG-Q), Berg Balance Scale (BBS), Ten-Meter Walking Test (10-MWT), and Time Up and Go Test (TUG), Non-Motor Symptoms Scale (NMSS), Beck Depression Inventory (BDI), PD questionnaire 39 (PDQ-39), MRI brain, uric acid, lipid profile and glycated hemoglobin were performed. Results: Significant worsening of MDS-UPDRS total, part III scores, H&Y, S&E and IPAQ (p < 0.001) was detected. One-year progression of H&Y and S&E were significantly correlated to disease duration (p = 0.014, p = 0.025, respectively). Progression of H&Y was correlated to baseline TUG (p = 0.035). S&E progression was correlated to baseline MDS-UPDRS total score (rho = 0.478, p = 0.001) and part III (rho = 0.350, p = 0.020), H&Y (rho = 0.401, p = 0.007), PIGD (rho = 0.591, p < 0.001), NFOG-Q (rho = 0.498, p = 0.001), and TUG (rho = 0.565, p = 0.001). Using linear regression, there was no predictors of clinical progression among the used baseline variables. Conclusion: Despite the significant motor and physical activity progression over 1 year that was correlated to baseline motor and gait severity, but without predictive value, further similar and longitudinal studies are warranted to detect predictors of early progression and confirm findings. Supplementary information: The online version contains supplementary material available at 10.1186/s41983-022-00445-1.

First Page

1

Last Page

10

This document is currently not available here.

Find this item online

Share

COinS